文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

影响新型抗 HIV 嵌合抗原受体(CAR)构建体表面 CD4 表达的细胞外结构域、铰链和跨膜决定因素。

Extracellular domain, hinge, and transmembrane determinants affecting surface CD4 expression of a novel anti-HIV chimeric antigen receptor (CAR) construct.

机构信息

Tulane National Primate Research Center, Tulane University School of Medicine, Covington, Louisiana, United States of America.

BioMedical Sciences Program, Tulane University School of Medicine, New Orleans, Louisiana, United States of America.

出版信息

PLoS One. 2024 Aug 12;19(8):e0293990. doi: 10.1371/journal.pone.0293990. eCollection 2024.


DOI:10.1371/journal.pone.0293990
PMID:39133676
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11318886/
Abstract

Chimeric antigen receptor (CAR)-T cells have demonstrated clinical potential, but current receptors still need improvements to be successful against chronic HIV infection. In this study, we address some requirements of CAR motifs for strong surface expression of a novel anti-HIV CAR by evaluating important elements in the extracellular, hinge, and transmembrane (TM) domains. When combining a truncated CD4 extracellular domain and CD8α hinge/TM, the novel CAR did not express extracellularly but was detectable intracellularly. By shortening the CD8α hinge, CD4-CAR surface expression was partially recovered and addition of the LYC motif at the end of the CD8α TM fully recovered both intracellular and extracellular CAR expression. Mutation of LYC to TTA or TTC showed severe abrogation of CAR expression by flow cytometry and confocal microscopy. Additionally, we determined that CD4-CAR surface expression could be maximized by the removal of FQKAS motif at the junction of the extracellular domain and the hinge region. CD4-CAR surface expression also resulted in cytotoxic CAR T cell killing of HIV Env+ target cells. In this study, we identified elements that are crucial for optimal CAR surface expression, highlighting the need for structural analysis studies to establish fundamental guidelines of CAR designs.

摘要

嵌合抗原受体 (CAR)-T 细胞已显示出临床潜力,但目前的受体仍需要改进,以成功对抗慢性 HIV 感染。在这项研究中,我们通过评估新型抗 HIV CAR 的细胞外区、铰链区和跨膜 (TM) 区中的重要元件,解决了 CAR 基序对强表面表达的一些要求。当结合截断的 CD4 细胞外结构域和 CD8α 铰链/TM 时,新型 CAR 不能在细胞外表达,但可在细胞内检测到。通过缩短 CD8α 铰链,CD4-CAR 的表面表达部分恢复,在 CD8α TM 的末端添加 LYC 基序可完全恢复细胞内和细胞外 CAR 的表达。通过流式细胞术和共聚焦显微镜检测,LYC 突变为 TTA 或 TTC 会严重阻断 CAR 的表达。此外,我们确定通过去除细胞外结构域和铰链区连接处的 FQKAS 基序,可最大程度地提高 CD4-CAR 的表面表达。CD4-CAR 表面表达也导致 CAR T 细胞对 HIV Env+靶细胞的细胞毒性杀伤。在这项研究中,我们确定了对 CAR 表面表达至关重要的元件,突出了结构分析研究对于建立 CAR 设计基本准则的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a7/11318886/5dfadbcbb81e/pone.0293990.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a7/11318886/31568ddcab4f/pone.0293990.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a7/11318886/c21a0f96bbeb/pone.0293990.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a7/11318886/c5eae3b23083/pone.0293990.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a7/11318886/45a266172680/pone.0293990.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a7/11318886/982f8b89974c/pone.0293990.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a7/11318886/da0be03c0604/pone.0293990.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a7/11318886/5dfadbcbb81e/pone.0293990.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a7/11318886/31568ddcab4f/pone.0293990.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a7/11318886/c21a0f96bbeb/pone.0293990.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a7/11318886/c5eae3b23083/pone.0293990.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a7/11318886/45a266172680/pone.0293990.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a7/11318886/982f8b89974c/pone.0293990.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a7/11318886/da0be03c0604/pone.0293990.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09a7/11318886/5dfadbcbb81e/pone.0293990.g007.jpg

相似文献

[1]
Extracellular domain, hinge, and transmembrane determinants affecting surface CD4 expression of a novel anti-HIV chimeric antigen receptor (CAR) construct.

PLoS One. 2024

[2]
Extracellular domain, hinge, and transmembrane determinants affecting surface CD4 expression of a novel anti-HIV chimeric antigen receptor (CAR) construct.

bioRxiv. 2023-10-26

[3]
Chimeric antigen receptor (CAR) T-cell therapy for people with relapsed or refractory diffuse large B-cell lymphoma.

Cochrane Database Syst Rev. 2021-9-13

[4]
A new sort of cells for chimeric antigen receptor T-cell therapies-isolating CD14CD127 T cells for chimeric antigen receptor T-cell manufacture.

Cytotherapy. 2025-4-18

[5]
Membrane-bound IL-7 immobilized by the CD8 transmembrane region improves efficacy of CD19 CAR-T cell therapy.

Mol Cancer. 2024-10-23

[6]
Persistence of CMV-specific anti-HIV CAR T cells after adoptive immunotherapy.

J Virol. 2025-5-20

[7]
Recent advances on anti-HIV chimeric antigen receptor-T-cell treatment to provide sustained HIV remission.

Curr Opin HIV AIDS. 2024-7-1

[8]
Activation of Cell-Intrinsic Signaling in CAR-T Cells via a Chimeric IL7R Domain.

Cancer Res Commun. 2024-9-1

[9]
In vitro machine learning-based CAR T immunological synapse quality measurements correlate with patient clinical outcomes.

PLoS Comput Biol. 2022-3

[10]
Metabolic reprogramming via an engineered PGC-1α improves human chimeric antigen receptor T-cell therapy against solid tumors.

J Immunother Cancer. 2023-3

引用本文的文献

[1]
Chimeric antigen receptor therapies: Development, design, and implementation.

J Allergy Clin Immunol. 2025-7

本文引用的文献

[1]
Stem cell-derived CAR T cells show greater persistence, trafficking, and viral control compared to ex vivo transduced CAR T cells.

Mol Ther. 2024-4-3

[2]
Evaluation of the Elements of Short Hairpin RNAs in Developing shRNA-Containing CAR T Cells.

Cancers (Basel). 2023-5-20

[3]
Assessment of anti-CD20 antibody pre-treatment for augmentation of CAR-T cell therapy in SIV-infected rhesus macaques.

Front Immunol. 2023

[4]
Allogeneic gene-edited HIV-specific CAR-T cells secreting PD-1 blocking scFv enhance specific cytotoxic activity against HIV Env cells invivo.

Virol Sin. 2023-4

[5]
Development of an anti-CAR antibody response in SIV-infected rhesus macaques treated with CD4-MBL CAR/CXCR5 T cells.

Front Immunol. 2022

[6]
HIV-Specific CAR T Cells with CD28 or 4-1BB Signaling Domains Are Phenotypically and Functionally Distinct and Effective at Suppressing HIV and Simian Immunodeficiency Virus.

Immunohorizons. 2022-10-11

[7]
Efficient derivation of chimeric-antigen receptor-modified T cells.

Front Immunol. 2022

[8]
CAR/CXCR5-T cell immunotherapy is safe and potentially efficacious in promoting sustained remission of SIV infection.

PLoS Pathog. 2022-2

[9]
Immune inactivation of anti-simian immunodeficiency virus chimeric antigen receptor T cells in rhesus macaques.

Mol Ther Methods Clin Dev. 2021-6-24

[10]
Broadly neutralizing antibody-derived CAR T cells reduce viral reservoir in individuals infected with HIV-1.

J Clin Invest. 2021-10-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索